| 000 | 01873 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515225344.0 | ||
| 264 | 0 | _c20110210 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.149 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReid, Ian R | |
| 245 | 0 | 0 |
_aEffects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cOct 2010 |
||
| 300 |
_a2256-65 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aRANK Ligand _xtherapeutic use |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aMiller, Paul D | |
| 700 | 1 | _aBrown, Jacques P | |
| 700 | 1 | _aKendler, David L | |
| 700 | 1 | _aFahrleitner-Pammer, Astrid | |
| 700 | 1 | _aValter, Ivo | |
| 700 | 1 | _aMaasalu, Katre | |
| 700 | 1 | _aBolognese, Michael A | |
| 700 | 1 | _aWoodson, Grattan | |
| 700 | 1 | _aBone, Henry | |
| 700 | 1 | _aDing, Beiying | |
| 700 | 1 | _aWagman, Rachel B | |
| 700 | 1 | _aSan Martin, Javier | |
| 700 | 1 | _aOminsky, Michael S | |
| 700 | 1 | _aDempster, David W | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 25 _gno. 10 _gp. 2256-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.149 _zAvailable from publisher's website |
| 999 |
_c19883645 _d19883645 |
||